The Insider – Meet the Fund Manager – Luke Winchester

The Insider

Meet the Fund Manager

Luke Winchester

Founder and Portfolio Manager | Merewether Capital

The Insider sessions are a great way to hear directly from leading fund managers. They share their approach to investing, favourite companies and their market view for the year ahead.**

Favourite Stocks

Hear about this fintech software company, its tie-up with the Federal Government, and how it was affected by lockdowns but Merewether believes it is poised to perform well over the next 2-3 years.

October 8th, 2021

Learn about this healthcare solutions provider grew its revenue by 25% despite COVID limitations in FY21 and how it’s best-in-class product is set to disrupt the market.

October 8th, 2021

Learn how this healthcare solutions provider grew its revenue by 25% despite COVID limitations in FY21 and how its best-in-class product is set to disrupt the market.

October 8th, 2021

Like these investment ideas? Join our next session to discover more like this by clicking here

Insights

Luke expresses his views on inflation and how government institutions are reacting, cashed-up consumers, COVID-beneficiaries and what the reopening trade means for stocks.

October 8th, 2021

Luke outlines the opportunities and risks for stock in the reopening trade, including healthcare, mining, enterprise software, Fintech, travel and more.

October 8th, 2021

Luke Winchester joins us to talk about Merewether’s three favourite stocks, how it identifies high-performing stocks, how investors can gain an edge by looking beyond market trends, and more.

October 8th, 2021

Close

Register your details



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Markets are the advisors assisting with the management of this offer and may receive fees depending on whether an offer is taken up by investors.

Meet the Fund Manager

Upcoming Session

Dean FergieDirector & Portfolio ManagerCyan Investment Management

Friday, 22nd October 12pm (AEDT)

This exclusive event gives investors unprecedented access to Australia’s leading fund managers to hear about their favourite companies, unique market insights, and the opportunity to ask questions.

This is an opportunity to hear from Dean Fergie, Director & Portfolio Manager at Cyan Investment Management.

Join Dean to learn about:

  • Cyan’s 3 favourite stocks
  • Market outlook and insights
  • Investment strategy and approach

This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited – book now to access this FREE event.

Book into the next session

What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.

Dean Fergie

Cyan Investment Management
Director & Portfolio Manager

Cyan is a high net worth, ‘true boutique’ investment management company that is trustee and manager for its C3G Fund. Since its inception in 2014, the fund has been one of the strongest-performing smallcap funds in Australia, delivering returns to investors in excess of 15% per annum with its ahead-of-the-curve strategy. Dean Fergie, Director and Portfolio Manager, co-founded the company with the objective of delivering meaningful and positive long-term returns to investors with its conservative and considered approach. Dean, a highly qualified finance professional, has more than 25 years’ experience in funds management across all major asset classes.

Past Sessions

Robert Calnon OC Funds Management

Hear about OC Funds Management, whose microcap fund was recently crowned Australia’s best-performing microcap fund by Morningstar (total return over five years). Robert Calnon, one of OC’s three highly experienced portfolio managers, shares his smallcap investing insights with us.

Matt McNamara Horizon 3 Biotech

Matt is a specialist in human healthcare technology and is passionate about investing in the commercialisation of this industry. He has spent more than 30 years in the healthcare and medical sciences sector and has more than 20 years’ experience as a venture capitalist. His business acumen and strong background in the life sciences sector make him one of the industry’s most credible investment voices.

David Keelan & Alexandra Clarke Ellerston Capital

Alexandra has worked in the finance market for 11 years and has extensive market IPO and pre-IPO experience. She provides in-depth research and analysis of stocks that range from micro to large caps covering the Industrial sector. David is a specialist investment manager with a distinctive approach to portfolio construction and investment selection.

** Reach does not assume responsibility for the accuracy or completeness of any information provided, and the views expressed are not reflective of Reach Markets position. Any advice contained within this presentation is general advice and does not consider your personal circumstance, you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only. “Investing is about understanding your risk” and every time you invest in the share market there is a risk of loss.

Reach Markets

Reach Markets Pty Ltd - ABN 36 145 312 232

Is a Corporate Authorised Representative (CAR No:431191) of:

Reach Financial Group - ABN 17 090 611 680 AFSL Number 333297

Level 8, 525 Flinders Street, Melbourne Victoria

Level 24, Royal Exchange Building, 56 Pitt Street, Sydney, NSW 2000 Australia

T: 1300 80 57 95    

E: admin@reachmarkets.com.au

Neori theme, designed by litMotion Templates

Contact Luke Winchester Directly